Agilent Technologies Return on Tangible Equity 2010-2025 | A

Current and historical return on tangible equity values for Agilent Technologies (A) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Agilent Technologies Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-01-31 $1.26B $1.08B 94.34%
2024-10-31 $1.29B $0.87B 85.48%
2024-07-31 $1.41B $1.55B 86.05%
2024-04-30 $1.24B $1.83B 81.52%
2024-01-31 $1.24B $1.78B 93.94%
2023-10-31 $1.24B $1.41B 115.32%
2023-07-31 $1.13B $1.07B 132.40%
2023-04-30 $1.35B $1.00B 204.31%
2023-01-31 $1.32B $0.82B 277.07%
2022-10-31 $1.25B $0.53B 370.18%
2022-07-31 $1.33B $0.29B 422.93%
2022-04-30 $1.26B $0.27B 561.33%
2022-01-31 $1.21B $0.26B 1258.49%
2021-10-31 $1.21B $0.43B 928.98%
2021-07-31 $0.99B $-0.06B 750.00%
2021-04-30 $0.93B $-0.25B 339.76%
2021-01-31 $0.81B $0.40B 202.12%
2020-10-31 $0.72B $0.44B 204.84%
2020-07-31 $0.69B $0.50B 273.12%
2020-04-30 $0.68B $0.27B 166.38%
2020-01-31 $0.76B $0.20B 107.15%
2019-10-31 $1.07B $0.05B 107.40%
2019-07-31 $1.07B $1.13B 84.94%
2019-04-30 $1.12B $1.48B 88.67%
2019-01-31 $1.14B $1.34B 86.87%
2018-10-31 $0.32B $1.11B 23.13%
2018-07-31 $0.30B $1.12B 19.15%
2018-04-30 $0.24B $1.69B 14.09%
2018-01-31 $0.20B $1.55B 12.10%
2017-10-31 $0.68B $1.87B 43.77%
2017-07-31 $0.63B $1.62B 44.44%
2017-04-30 $0.58B $1.43B 42.70%
2017-01-31 $0.51B $1.33B 39.63%
2016-10-31 $0.46B $1.31B 37.96%
2016-07-31 $0.48B $1.38B 38.75%
2016-04-30 $0.46B $1.12B 38.66%
2016-01-31 $0.46B $1.06B 36.90%
2015-10-31 $0.40B $1.36B 30.56%
2015-07-31 $0.28B $1.26B 18.35%
2015-04-30 $0.31B $1.30B 18.82%
2015-01-31 $0.37B $1.33B 20.61%
2014-10-31 $0.50B $2.15B 27.14%
2014-07-31 $0.69B $1.87B 42.56%
2014-04-30 $0.71B $1.74B 52.01%
2014-01-31 $0.74B $1.57B 58.57%
2013-10-31 $0.72B $1.33B 61.70%
2013-07-31 $0.94B $0.85B 84.47%
2013-04-30 $1.01B $1.31B 91.47%
2013-01-31 $1.10B $1.21B 75.26%
2012-10-31 $1.15B $1.07B 64.66%
2012-07-31 $1.02B $0.84B 48.55%
2012-04-30 $1.10B $2.73B 45.53%
2012-01-31 $1.05B $2.49B 47.26%
2011-10-31 $1.01B $2.32B 51.80%
2011-07-31 $1.02B $2.16B 59.87%
2011-04-30 $0.89B $1.91B 64.48%
2011-01-31 $0.80B $1.42B 58.35%
2010-10-31 $0.68B $1.29B 46.86%
2010-07-31 $0.42B $0.90B 26.71%
2010-04-30 $0.19B $1.86B 11.00%
2010-01-31 $-0.02B $1.79B -0.95%
2009-10-31 $-0.03B $1.69B -1.87%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $38.594B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $234.047B 28.90
Boston Scientific (BSX) United States $154.056B 41.59
Stryker (SYK) United States $148.022B 31.82
EssilorLuxottica (ESLOY) France $137.298B 0.00
Medtronic (MDT) Ireland $115.624B 16.89
Lonza Group Ag (LZAGY) Switzerland $46.792B 0.00
Haleon (HLN) United Kingdom $45.950B 29.85
GE HealthCare Technologies (GEHC) United States $41.418B 20.17
ResMed (RMD) United States $33.728B 25.98
Terumo (TRUMY) Japan $25.984B 36.95
Koninklijke Philips (PHG) Netherlands $24.420B 17.44
Zimmer Biomet Holdings (ZBH) United States $21.098B 13.25
Insulet (PODD) United States $19.908B 85.13
Baxter (BAX) United States $17.948B 12.94
Smith & Nephew SNATS (SNN) United Kingdom $11.490B 0.00
Sunny Optical Technology (SNPTF) China $11.331B 0.00
BellRing Brands (BRBR) United States $9.348B 35.03
Demant (WILYY) Denmark $8.092B 0.00
Bio-Rad Laboratories (BIO) United States $7.847B 27.17
Lantheus Holdings (LNTH) United States $5.489B 12.75
Prestige Consumer Healthcare (PBH) United States $4.215B 20.11
ICU Medical (ICUI) United States $3.924B 37.35
Envista Holdings (NVST) United States $3.683B 29.30
Perrigo (PRGO) Ireland $3.443B 10.14
Haemonetics (HAE) United States $3.312B 15.58
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
GN Store Nord (GNNDY) Denmark $2.850B 19.20
QuidelOrtho (QDEL) United States $2.822B 23.71
LeMaitre Vascular (LMAT) United States $2.294B 55.75
Neogen (NEOG) United States $2.261B 26.05
AtriCure (ATRC) United States $1.916B 0.00
Green Thumb Industries (GTBIF) United States $1.494B 26.06
InMode (INMD) Israel $1.330B 11.12
BioLife Solutions (BLFS) United States $1.193B 0.00
AdaptHealth (AHCO) United States $1.150B 8.22
Maravai LifeSciences Holdings (MRVI) United States $1.013B 0.00
Curaleaf Holdings (CURLF) Canada $0.920B 0.00
CeriBell (CBLL) United States $0.911B 0.00
Phibro Animal Health (PAHC) United States $0.896B 13.74
Evolus (EOLS) United States $0.893B 0.00
Capricor Therapeutics (CAPR) United States $0.657B 0.00
Valneva SE (VALN) France $0.635B 0.00
VAREX IMAGING (VREX) United States $0.538B 23.32
Omeros (OMER) United States $0.503B 0.00
Surmodics (SRDX) United States $0.501B 0.00
Owens & Minor (OMI) United States $0.493B 3.85
SNDL (SNDL) Canada $0.439B 0.00
Cresco Labs (CRLBF) United States $0.432B 0.00
ZimVie (ZIMV) United States $0.368B 30.98
SEMPERIT AG HLD (SEIGY) Austria $0.349B 0.00
Verano Holdings (VRNOF) United States $0.349B 0.00
Quanterix (QTRX) United States $0.311B 0.00
Sanara MedTech (SMTI) United States $0.309B 0.00
Aurora Cannabis (ACB) Canada $0.308B 56.10
Cerus (CERS) United States $0.305B 0.00
Viemed Healthcare (VMD) United States $0.300B 28.52
OraSure Technologies (OSUR) United States $0.298B 19.95
Biote (BTMD) United States $0.252B 5.52
Canopy Growth (CGC) Canada $0.252B 0.00
Zynex (ZYXI) United States $0.234B 49.07
Sanuwave Health (SNWV) United States $0.231B 3.24
High Tide (HITI) Canada $0.205B 0.00
Utah Medical Products (UTMD) United States $0.204B 15.21
Brainsway (BWAY) Israel $0.184B 97.80
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
MacroGenics (MGNX) United States $0.166B 0.00
TerrAscend (TSNDF) Canada $0.164B 0.00
Organigram Holdings (OGI) Canada $0.154B 0.00
FitLife Brands (FTLF) United States $0.137B 17.17
Jin Medical (ZJYL) China $0.114B 0.00
Quipt Home Medical (QIPT) United States $0.114B 0.00
Fonar (FONR) United States $0.092B 12.92
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Veru (VERU) United States $0.083B 0.00
InterCure (INCR) Israel $0.076B 0.00
Jushi Holdings (JUSHF) United States $0.069B 0.00
Exagen (XGN) United States $0.063B 0.00
Cytosorbents (CTSO) United States $0.060B 0.00
Rockwell Medical (RMTI) United States $0.057B 29.17
Apyx Medical (APYX) United States $0.054B 0.00
Hongchang (HCIL) China $0.051B 0.00
United-Guardian (UG) United States $0.046B 13.24
ImmuCell (ICCC) United States $0.045B 0.00
Modular Medical (MODD) United States $0.042B 0.00
INLIF (INLF) $0.032B 0.00
Safety Shot (SHOT) United States $0.028B 0.00
Nephros (NEPH) United States $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
Allurion Technologies (ALUR) United States $0.009B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00